Ventana is committed to our mission — to improve the lives of all patients afflicted with cancer.
Our culture of constant innovation fuels our vision: to empower our customers by providing the highest quality, most innovative cancer diagnostic solutions. We are passionate in our pursuit of diagnostic leadership because when we empower pathology professionals, we improve the outlook for patients.
Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide.
Passionately pursuing their mission to improve the lives of all patients afflicted with cancer, the people of Ventana discover, develop, and deliver medical diagnostic systems and biopsy based cancer tests that are shaping the future of healthcare. As the leading supplier of cancer diagnostic systems to the pathology market, Ventana manufactures over 220 cancer tests with related instruments right here in southern Arizona for 80 countries, and most importantly, for 4 million people afflicted with cancer yearly around the world. Ventana products provide healthcare professionals with a total solution for all critical steps involved in the analysis of tissue biopsies. This pioneering company also offers premier workflow solutions to improve laboratory efficiency and preserve patient safety.
Linking the most accurate diagnosis with the most targeted and relevant therapeutic is the essence of Personalized Healthcare. The value of the Personalized Healthcare approach is rooted in positive outcomes for the patient—saving lives and improving the quality of life. Ventana is committed to accelerating the discovery and development of new cancer tests that allow pathologists to analyze patient samples at the molecular level to help determine the best course of therapy for each individual patient. Ventana enables this with its global leadership as the #1 Pharma Industry Partner of Choice in the development and commercialization of companion diagnostics for cancer patients.
As a member of the Roche Group, drawing on powerful partnerships with world-class scientific institutions, there is no other company in the world in a better position to make this approach a reality.